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Abstract
© Schattauer 2015. Atherosclerosis is primarily a disorder of lipid metabolism, but there is also
a prominent chronic inflammatory component that drives the atherosclerotic lesion progression
in  the artery  wall.  During hyperlipidaemic conditions,  there is  a  rapid  influx of  circulating
monocytes  into  the  atherosclerosis-prone  areas  of  the  arterial  intima.  These  infiltrated
monocytes differentiate into macrophages and take up the atherogenic lipoproteins in the
intima of the vessel wall that have been modified within the lesion environment. Interleukin (IL)-
10 is a prototypic anti-inflammatory cytokine made primarily by the macrophages and Th2
subtype  T  lymphocytes.  In  terms  of  atherosclerosis  its  major  roles  include  inhibition  of
macrophage  activation  as  well  as  inhibition  of  matrix  metalloproteinase,  pro-inflammatory
cytokines and cyclooxygenase- 2 expression in lipid-loaded and activated macrophage foam
cells. Recent discoveries suggest another important role of IL-10 in atherosclerosis: its ability to
alter lipid metabolism in macrophages. The current review will highlight the present knowledge
on multiple ways in which IL-10 mediates atherosclerosis. As macrophages play a critical role in
all stages of atherosclerosis, the review will concentrate on how IL-10 regulates the activities of
macrophages that are especially important in the development of atherosclerosis.
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